Abstract
Campylobacter jejuni is the most common cause of bacterial gastroenteritis worldwide. Mainly isolated from stool samples, C. jejuni can also become invasive. C. jejuni belongs to the commensal microbiota of a number of hosts, and infection by this bacterium can sometimes be traced back to exposure to a specific source. Here we genome sequenced 200 clinical isolates (2010–2016) and analyzed them with 701 isolate genomes from human infection, chicken, ruminants and the environment to examine the relative contribution of different reservoirs to non-invasive and invasive infection in France. Host-segregating genetic markers that can discriminate C. jejuni source were used with STRUCTURE software to probabilistically attribute the source of clinical strains. A self-attribution correction step, based upon the accuracy of source apportionment within each potential reservoir, improved attribution accuracy of clinical strains and suggested an important role for ruminant reservoirs in non-invasive infection and a potentially increased contribution of chicken as a source of invasive isolates. Structured sampling of Campylobacter in the clinic and from potential reservoirs provided evidence for variation in the contribution of different infection sources over time and an important role for non-poultry reservoirs in France. This provides a basis for ongoing genomic epidemiology surveillance and targeted interventions.
Original language | English |
---|---|
Article number | 8098 |
Pages (from-to) | 1-8 |
Number of pages | 8 |
Journal | Scientific Reports |
Volume | 9 |
Issue number | 1 |
DOIs | |
Publication status | Published - 30 May 2019 |
Funding
We thank Lindsay Mégraud for her help with correcting the manuscript. We also thank Michèle Gourmelon for her work isolating the environmental strains, as well as everyone who participate in some way to increase the size and quality of the isolates publically available. Their effort makes studies like ours exist. This work was supported by internal funding of the CNRCH. SS is funded by UK Medical Research Council (MRC) grants MR/L015080/1, MR/M501608/1 and G0801929, Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/ I02464X/1, and the Wellcome Trust.
ASJC Scopus subject areas
- General